More than 25 years of research and drug development, and recognized as the key architect of LLS's cures and access agenda.
Lee Greenberger, Ph.D.,
Chief Scientific Officer
Over 25 years of experience in discovery and development of Oncology drugs. Leads planning and strategy for LLS research programs.
Gwen Nichols, MD,
Chief Medical Officer
A hematologist and scientific researcher, Nichols oversees LLS’s scientific research portfolio, patient services and policy and advocacy initiatives.
Director, Information Resource Center
Leads LLS's team of information specialists, master’s trained health professionals with expertise in the blood cancers who help patients understand their diagnosis, find treatment options, find clinical trials and navigate the financial burdens of healthcare.
Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: